Express News | T2 Biosystems Receives Notice Of Allowance For U.S. Patent Titled 'METHODS AND SYSTEMS FOR AMPLIFICATION IN COMPLEX SAMPLES (INCLUDING DIAGNOSTIC AND THERAPEUTICS METHODS FOR PATHOGENS IN WHOLE BLOOD)'
BenzingaApr 25 13:55 ET
T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024
LEXINGTON, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today t
T2 BiosystemsApr 24 00:00 ET
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial results.Nucor reported quarterly earnings of $3.46 per s
BenzingaApr 23 13:53 ET
Bio-Path Holdings, Sunshine Biopharma, INVO Bioscience Among Healthcare Movers
Seeking AlphaApr 23 10:00 ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersImmunityBio (NASDAQ:IBRX) shares moved upwards by 32.0% to $6.52 during Tuesday's pre-market session. The company's market cap stands at $4.4 billion. Nuwellis (NASDAQ:NUWE) shares increased by
BenzingaApr 23 08:06 ET
Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Shares of Hibbett, Inc. (NASDAQ:HIBB) rose sharply in today's pre-market trading after the company agreed to be acquired by JD Sports Fashion for $87.50 per share in cash, in a $1.1 billion transactio
BenzingaApr 23 08:00 ET
Top Premarket Decliners
Abeona Therapeutics (ABEO) shares slumped 48% Tuesday premarket after the company said that it plans to resubmit its biologic license application for pz-cel after the US Food and Drug Administration h
MT NewswiresApr 23 07:39 ET
T2 Biosystems to Offer Stock and Warrants
T2 Biosystems to Offer Stock and Warrants
Dow JonesApr 22 17:16 ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersAdial Pharmaceuticals (NASDAQ:ADIL) stock rose 34.2% to $2.59 during Monday's pre-market session. The company's market cap stands at $10.5 million. NKGen Biotech (NASDAQ:NKGN) shares moved upwa
BenzingaApr 22 08:07 ET
Why Riot Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Shares of Riot Platforms, Inc. (NASDAQ:RIOT) rose sharply in today's pre-market trading amid a rise in Bitcoin.Bitcoin (CRYPTO: BTC) prices gained around 1.5% over the past 24 hours to $66,012 this mo
BenzingaApr 22 05:23 ET
Express News | T2 Biosystems Shareholders Vote For Approval Of Conversion Of $15M Of Its Term Loan With Entities Affiliated With CRG Servicing
Moomoo 24/7Apr 11 16:09 ET
Express News | T2 Biosystems - Stockholders Voted for Approval of Conversion of $15 Mln of Term Loan With Entities Affiliated With Crg Into T2 Biosystems Equity
Moomoo 24/7Apr 11 16:05 ET
Express News | T2 Biosystems Shareholders Vote for Crg Debt Conversion Into Equity
Moomoo 24/7Apr 11 16:05 ET
Press Release: T2 Biosystems Shareholders Vote for CRG Debt Conversion Into Equity
T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity LEXINGTON, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-c
Dow JonesApr 11 16:05 ET
T2 Biosystems Shareholders Vote for CRG Debt Conversion Into Equity
LEXINGTON, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced r
T2 BiosystemsApr 11 00:00 ET
T2 Biosystems Reinforces Market Position With Extended Vizient Agreement
TipRanksMar 28 16:53 ET
Express News | T2 Biosystems Extends Multi-Year Capital Equipment Supplier Agreement With Vizient; Vizient Members Continue Access To Broader Exposure And Contracted Pricing For T2Dx Instrument, T2Bacteria Panel And T2Candida Panel
Moomoo 24/7Mar 28 09:02 ET
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement With Vizient, Inc.
LEXINGTON, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced t
T2 BiosystemsMar 28 00:00 ET
T2 Biosystems Anticipates Breakthroughs and Extends NASDAQ Compliance
TipRanksMar 20 09:32 ET
T2 Biosystems Targets Commercial Launch Of T2Lyme Panel In Q3 - Quick Facts
RTTNewsMar 20 08:27 ET
No Data
No Data